A review of European guidelines on periconceptional folic acid supplementation

European Journal of Clinical Nutrition

Volumn 70, Issue 2, 2016, Pages 143-154

  Cawley, S ^a   Mullaney, L ^a   McKeating, A ^b   Farren, M ^a   McCartney, D ^a   Turner, M J ^b  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BELGIUM; CROATIA; DENMARK; DIABETES MELLITUS; EPILEPSY; EUROPE; EVIDENCE BASED MEDICINE; FINLAND; FRANCE; GERMANY; HEALTH PROGRAM; HUMAN; HUNGARY; IRELAND; ITALY; MALTA; MATERNAL AGE; MATERNAL CARE; MATERNAL NUTRITION; NETHERLANDS; NEURAL TUBE DEFECT; NORWAY; OBESITY; POLAND; PORTUGAL; PRACTICE GUIDELINE; PREGNANCY OUTCOME; REVIEW; RISK REDUCTION; SLOVENIA; SPAIN; SWEDEN; SWITZERLAND; TREATMENT DURATION; UNITED KINGDOM; VITAMIN SUPPLEMENTATION; ADULT; DIETARY SUPPLEMENT; FEMALE; NEURAL TUBE DEFECTS; NEWBORN; PREGNANCY; PREPREGNANCY CARE; STANDARDS;

FOLIC ACID; VITAMIN B COMPLEX;

ADULT; DIETARY SUPPLEMENTS; EUROPE; FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; NEURAL TUBE DEFECTS; PRACTICE GUIDELINES AS TOPIC; PRECONCEPTION CARE; PREGNANCY; VITAMIN B COMPLEX;

EID: 84956881072     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2015.131     Document Type: Review

References (62)

1. Copp AJ, Stanier P, Greene ND. Neural tube defects-recent advances, unsolved questions and controversies. Lancet Neurol 2013; 12: 799-810.
2. Yi Y, Lindemann M, Colligs A, Snowball C. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J Pediatr 2011; 170: 1391-1400.
3. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-137.
4. Czeizel A, Dudas I. Prevention of the first occurrences of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835.
5. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005; 330: 571.
6. Mc Donnell R, Delaney V, O'Mahony MT, Mullaney C, Lee B, Turner MJ. Neural tube defects in the Republic of Ireland in 2009-11. J Public Health 2014; 37: 57-63.
7. Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5methyl tetrahydrafolae than with folic acid in women of childbearing age. Am J Clin Nutr 2006; 84: 156-161.
8. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981; 56: 911-918.
9. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification. Pediatrics 2009; 123: 917-923.
10. Crider KS, Devine O, Hao L, Dowling NF, Li S, Molloy AM et al. Population of red blood cell folate concentration for prevention of neural tube defects: Bayesian model. BMJ 2014; 349: g4554.
11. Norsworthy B, Skeaff CM, Adank C, Green TJ. Effects of once-A-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr 2004; 58: 548-554.
12. Hurthouse NA, Gray AR, Miller JC, Rose MC, Houghton LA. Folate status of reproductive age women and neural tube defect risk-the effect of long term folic acid supplementation at doses of 140 μg and 400 μg per day. Nutrients 2011; 3: 49-62.
13. McNulty B, Pentieva K, Marshall B, Ward M, Molloy AM, Scott JM et al. Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Hum Reprod. 2011; 2: 1530-1536.
14. Pollak A, Gruber W, Birnbacher R, Zwiauer K. Richtlinien zur Praevention von Neuralrohredefekten durch perikonzeptionelle Folsaeuresubstitution. Gynaekologischgeburtshilfliche Rundschau 1998; 38: 55-56.
15. EUROCAT Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe-December 2009-Country Specific Chapters-Report on periconceptional supplementation for Belgium. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-Bel gium.pdf (accessed April 2015).
16. EUROCAT Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe-December 2009-Country Specific Chapters-Report on periconceptional supplementation for Croatia. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-Croatia.pdf (accessed April 2015).
17. Rasmussen LB, Andersen NL, Andersson G, Lange AP, Rasmussen K, Skak-Iversen L et al. Folate and neural tube defects: Recommendations from a Danish working group. Dan Med Bull 1998; 45: 213-217.
18. Sosiaali-ja terveysministerion asiantuntijaryhma. Hoitosuositus. Foolihappo ja hermostoputken sulkeutumishäiriöt 1995. 33/623/95.
19. Stakes (1999). Seulontatutkimukset jayhteistyö äitiyshuollossa. Suositukset Oppaita 34. Viisainen K (toim). Helsinki.
20. Hasunen K, Kalavainen M, Keinonen H, Lagström H, Lyytikäinen A, Nurttila A et al. The Child, Family and Food. Nutrition recommendations for infants and young children as well as pregnant and breastfeeding mothers. Publications of the Ministry of Social Affairs and Health Helsinki 2004. 11.
21. EUROCAT Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe-December 2009-Country Specific Chapters-Report on periconceptional supplementation for France. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-France.pdf.
22. Dehé S, Vodovar V, Vérité V, Goujard J. Prevention primaire des anomalies de fermeture du tube neural par supplementation periconceptionnelle en acide folique. Situation à Paris en 1999 (Primary prevention of neural tube defects by supplementation in folic acid. 1999 status in Paris)'. BEH 2000; 21: 87-89.
23. Koletzko B, von Kries R. Prävention von Neural rohrdefekten durch Folsäurezufuhr in der Frühschwangerschaft. Der Frauenarzt 1994; 35: 1007-1010.
24. Koletzko B, von Kries R. Prävention von Neural rohrdefekten durch Folsäurezufuhr in der Frühschwangerschaft. Der Kinderarzt 1995; 26: 187-190.
25. Deutsche Gesellschaft für Ernährung (DGE) (2000). Ernährungsbericht 2000. Bonn.
26. EUROCAT Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe-December 2009-Country Specific Chapters-Report on periconceptional supplementation for Hungary. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-Hungary.pdf (accessed 26. August 2015).
27. Szülészeti és No′gyógyászati Szakmai Kollégium (National Board of Hungarian Gynaecologists). Szakmai állásfoglalás a terhesség alatti vitamin és ásványi anyag supplementatio kérdéséro′l (Guideline for vitamin and mineral supplementation during pregnancy). Magyar No′orvosok Lapja 1999; 62: 63-65.
28. Department of Health, Republic of Ireland. Folic Acid and the Prevention of Neural Tube Defects. Department of Health Publications Unit: Dublin, 1992.
29. Health Education Authority Ireland. Folic Acid and the Prevention of Neural Tube Defects-A Summary Guide for Health Professionals. Department of Health Library and Information's Unit: Dublin, 1996.
30. Food Safety Authority of Ireland. The Value of FA in Prevention of Neural Tube Defects. Department of Health Library and Information's Unit: Dublin, 1997.
31. Institute of Obstetrics and Gynaecologists, Royal College of Physicians of Ireland and Clinical Strategy and Programmes Directorate. Health Service Executive. Obesity and pregnancy-Clinical Practice Guideline. Health Service Executive: Dublin, 2011.
32. Acido Folico. Prove di efficacia e considerazioni utili per la riduzione del rischio di malformzioni congenite. Bolletino d'informazione sui farmaci. XI 2 2004.
33. Department of Public Health Malta. Department of Health Circular No 36/94: Circular regarding folic acid issued to all medical practitioners. 1994.
34. Gatt M, Periconceptional Folic Acid Supplementation in Malta, in 'Half Yearly Report of Malta Congenital Anomalies Register July-December 1999, Malta Congenital Anomalies Registry, Department of Health Information. 2000 [Online] Available http://www.sahha.gov.mt/showdoc.aspx?id = 43&filesource = 4&file = hyjuly-dec1999.pdf) (accessed April 2015).
35. Gezondheidsraad/ Voedingsraad (1993). Continued advice concerning folic acid use in relation to neural tube defects. [Vervolgadvies inzake foliumzuurvoorziening in relatie tot neuraalbuisdefecten.]. Den Haag, Voorlichtingsbureau van de Voeding.
36. Statens helsetilsyn (Norweigan Board of Health) (1993). Tiltak som kan redusere forekomst av nevralrørsdefekter. Rundskriv IK-4/93.
37. Statens råd for ernæring og fysisk aktivitet (National Council on Nutrition and Physical Activity), spring 1998. Available at http://www.sef.no/ (accessed 26. August 2015).
38. Brzeziński Z. Primary prevention program for neural tube defects in Poland. Med Wieku Rozwoj 1999; 3: 503-508.
39. Directorate General of Health, Maternal, Child and Adolescence Division (1998). Preconceptional health care, 02/DSMIA.
40. Directorate General of Health, Maternal, Child and Adolescence Division (2006). Preconceptional health care, 02/DSMIA.
41. Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe-December 2009-Country Specific Chapters-Report on periconceptional supplementation for Slovenia. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-Slovenia.pdf (accessed April 2015).
42. Grupo Institucional (2003). Ministerio de Educación y Cultura y Ministerio de Interior. Nutrición Saludable y Prevención de los Trastornos Alimentarios. Available from http://www.msssi.gob.es/ (accessed April 2015).
43. Dirección de Salud Pública, Ministerio de Sanidad y Consumo Recomendaciones sobre suplementación con ácido fólico para la prevención de defectos del tubo neural. Inf Ter Sist Nac Salud 2001; 25: 66-67.
44. National Board of Health and Welfare (1996). Aktuellt i folsyra frågan. http://www. socialstyrelsen.se/ (accessed 26. August 2015).
45. National Board of Health and Welfare (2001). Folsyra I Samband medgraviditet. http://www.socialstyrelsen.se/ (accessed 26. August 2015).
46. Tönz O, Lüthy J. Folsäure zur primären Verhütung von Neuralrohrdefekten. Bulletin des Médecins Suisses 1996; 77: 569-57.
47. Baerlocher K, Eichholzer M, Lühy J, Moser U, Tönz O. Acide folique: Rapport d'experts de la commission fédérale d'alimentation sur la prophylaxie des anomalies du tube neural. Office fédéral de la santé publique, Berne 2002, p73.
48. Department of Health (1992). Folic Acid and the Prevention of Neural Tube Defect: Report from an Expert Advisory Group. Department of Health Publication Unit: Heywood.
49. National Institute for Health and Care Excellence (2008). Maternal and Child Nutrition. [Online] Available https://www.nice.org.uk/guidance/ph11/resources/ guidance-maternal-and-child-nutrition-pdf (accessed 26. August 2015).
50. National Health Services (2013). Vitamins and Nutrition in pregnancy. [Online] Available http://www.nhs.uk/conditions/pregnancy-and-baby/pages/vitamins-mineralssupplements-pregnant.aspx#close (accessed 26. August 2015).
51. National Health Service Scotland (2011). Folic acid: Before and during pregnancy. [Online] Available http://www.healthscotland.com/uploads/documents/20011-FolicAcidCard.pdf (accessed 26. August 2015).
52. Stamm RA, Houghton CA. Nutrient intake values for folate during pregnancy and lactation vary widely around the world. Nutrients 2013; 5: 3920-3947.
53. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for NTDs. Quarterly J Med 1993; 86: 703-708.
54. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H et al. Prevention of neural tube defects with FA in China.-Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341: 1485-1490.
55. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects: Implication for prevention. JAMA 1995; 274: 1698-1702.
56. Health Canada (2013). Prenatal Nutrition Guidelines for Health Professionals Folate Contributes to a Healthy Pregnancy. [Online] Available http://www.hc-sc.gc.ca/ fn-an/alt-formats/hpfb-dgpsa/pdf/pubs/folate-eng.pdf (accessed 26. August 2015).
57. Australian Government-Department of Health and Ageing (2012). Clinical Practice Guidelines Antenatal Care-Module 1. Commonwealth of Australia.
58. Moreau C, Bohet A, Le Guen M, Loilier AR, Bajos N. FECOND Group Unplanned or unwanted? A randomized study of national estimates of pregnancy intentions. Fertil Steril 2014; 102: 1663-1670.
59. Grosse SD, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Br Med J (Clin Res Ed) 1981; 282: 1509-1511.
60. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Birth Defects Res A Clin Mol Teratol 2007; 79: 737-742.
61. Indian Council of Medical Research. Multicentre study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian J Med Res 2000; 112: 206-221.
62. Kelly F, Gibney FR, Boilson A, Staines A, Sweeney MR. Folic acid levels in some food staples in Ireland are on the decline: implications for passive folic acid intake. J Public Health e-pub ahead of print 8. March 2015; doi:10.1093/pubmed/fdv025.